With AstraZeneca's announcement today of positive high-level results from an interim analysis of clinical trials of their vaccine candidate AZD1222, I felt compelled to post the picture above that highlights the differences between vaccines and antibody therapy. Antibody therapy is not a vaccine and should not be referred to as such.
AstraZeneca now has late-stage candidates in both categories. AZD1222 is an adenovirus vector vaccine candidate (astrazeneca.com/media-centr... and AZD7442 is a monoclonal therapy (astrazeneca.com/media-centr.... This may lead to confusion when discussing them on this forum so it will be important to specify which AstraZeneca product is being discussed.
I've added just a few of the antibody therapy and vaccine candidates to the figure. There are plenty more in the pipeline around the world!
bennevisplace, I'm excited and dizzy from trying to navigate the GEN site!😩 An almost overwhelming amount of info there! I've bookmarked the site and will be checking it frequently. Thanks very much for the link!
For immuno-compromised people who receive repeated IVIG due to low immunoglobulins, l think the mRNA vaccines offer the best chance to be effective for a long period of time.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.